Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1)
2008; Elsevier BV; Volume: 16; Issue: 8 Linguagem: Inglês
10.1016/j.bmc.2008.02.027
ISSN1464-3391
AutoresYasutomi Asano, Shuji Kitamura, Taiichi Ohra, Kazuyoshi Aso, Hideki Igata, Tomoko Tamura, Tomohiro Kawamoto, Toshimasa Tanaka, Satoshi Sogabe, Shin-ichi Matsumoto, Masashi Yamaguchi, Hiroyuki Kimura, Fumio Itoh,
Tópico(s)Cytokine Signaling Pathways and Interactions
ResumoA novel series of 4-phenylisoquinolones were synthesized and evaluated as c-Jun N-terminal kinase (JNK) inhibitors. Initial modification at the 2- and 3-positions of the isoquinolone ring of hit compound 4, identified from high-throughput screening, led to the lead compound 6b. The optimization was carried out using a JNK1-binding model of 6b and several compounds exhibited potent JNK inhibition. Among them, 11g significantly inhibited cardiac hypertrophy in rat pressure-overload models without affecting blood pressure and the concept of JNK inhibitors as novel therapeutic agents for heart failure was confirmed.
Referência(s)